The Administration and Biostatistics Core will provide centralized grant administration, communications, data sharing, and statistical analyses for the projects. This Core also serves to amalgamate the investigators, their experimental findings and their ideas, promote translational efforts and direct efforts toward the Program goals and outcomes. In addition, the Biostatistics and Data Integration part of this core will create and operate a secure web site for the interchange of data, communications, and the evaluation of Program progress.
Specific Aims i nclude:
Aim 1. Provide basic administrative services to the investigators. ? Service includes the management of supplies, filing, development of memos, meeting minutes and communications covering all operations. The Core will provide investigators with clear lines of scientific and administrative communication to promote collaboration, aid in the prioritization of resources, and facilitate resolution of any problems that affect team members. ? Provide publication services to the investigators for project-related communications.
Aim 2. Provide data management and statistical analyses for all projects. ? To collaborate with project investigators in the formulation of hypotheses and study design. ? To conduct and direct the statistical analysis of data including both descriptive summary statistics and sophisticated inferential procedures. ? Provide timely review, quality assurance, and dissemination of the results gleaned from investigations. ? To install data prioritization evaluation and an inter-institutional secure website for sharing and storing databases. Provide access in real-time to data sets and standardization of data sets to permit data managers from all institutions to have input on statistics and direct modeling and experimental design.
Aim 3. Organize Scientific and Advisory Board Meetings ? Monthly Steering Committee Meetings (Project Leaders, Core Directors, and key staff members). ? Weekly PPG Retrovirology Laboratory Scientific Data Meetings (all project members and their labs) ? Annual Internal and External Scientific Advisory Board (ISAB &ESAB) meetings. Panel of experts shall assess the Program effectiveness and experimental progress, research directions, statistical evaluation, and admin effectiveness. Each board will review experimental findings and translational outcomes, help prioritize investigations, review collaborations, and evaluate concepts that emerge.
Aim 4. Provide overall fiscal review, accounting, and real time budgets analyses.
The Administration and Biostatistics Core is essential for the functions of the Program as an engine for discovery and will provide critical support for planning of studies and design of experiments, statistical analyses and display of data, and data management and integrity. This support is designed to ensure that studies yield reliable conclusions, resources are efficiently used, and exploratory analyses uncover important leads.
|Panfil, Amanda R; Dissinger, Nathan J; Howard, Cory M et al. (2016) Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis. J Virol 90:3760-72|
|Esser, Alison K; Schmieder, Anne H; Ross, Michael H et al. (2016) Dual-therapy with Î±vÎ²3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model. Nanomedicine 12:201-11|
|Su, Xinming; Esser, Alison K; Amend, Sarah R et al. (2016) Antagonizing Integrin Î²3 Increases Immunosuppression in Cancer. Cancer Res 76:3484-95|
|Kawatsuki, A; Yasunaga, J-I; Mitobe, Y et al. (2016) HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells. Oncogene 35:4509-17|
|Murphy, Jane; Hall, William W; Ratner, Lee et al. (2016) Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles. Virology 494:129-42|
|Niewiesk, Stefan (2016) Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis. ILAR J 57:3-11|
|Panfil, Amanda R; Martinez, Michael P; Ratner, Lee et al. (2016) Human T-cell leukemia virus-associated malignancy. Curr Opin Virol 20:40-46|
|Kroep, J R; Charehbili, A; Coleman, R E et al. (2016) Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials. Eur J Cancer 54:57-63|
|Haines, Robyn A; Urbiztondo, Rebeccah A; Haynes 2nd, Rashade A H et al. (2016) Characterization of New Zealand White Rabbit Gut-Associated Lymphoid Tissues and Use as Viral Oncology Animal Model. ILAR J 57:34-43|
|Ratner, L; Rauch, D; Abel, H et al. (2016) Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood Cancer J 6:e408|
Showing the most recent 10 out of 146 publications